Journal of Electrocardiology
Volume 43, Issue 1 , Pages 68-70 , January 2010

Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report

Received 11 February 2009

References 

  1. Zipes DP, Wyse DG, Friedman PL, et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576
  2. Sudden Cardiac Death in Heart Failure Trial Investigators . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225
  3. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation. 1995;92:1651
  4. Healy E, Goyal S, Browning C, et al. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. Pacing Clin Electrophysiol. 2004;27:415
  5. Taylor E, Berger R, Hummel JD, et al. Analysis of the pattern of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol. 2000;11:719
  6. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247
  7. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111
  8. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol. 2007;18:326
  9. Catanchin A, Anderson L, Jones S, Ward D. When life-saving devices terminate life. J Cardiovasc Electrophysiol. 2008;19:316
  10. Olatidoye AG, Verroneau J, Kluger J. Mechanisms of syncope in implantable cardioverter-defibrillator recipients who receive device therapies. Am J Cardiol. 1998;82:1372
  11. Abello M, Merino JL, Peinado R, et al. Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia. Eur Heart J. 2006;27:89
  12. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1

PII: S0022-0736(09)00111-3

doi: 10.1016/j.jelectrocard.2009.03.016

Journal of Electrocardiology
Volume 43, Issue 1 , Pages 68-70 , January 2010

Article Tools

* Image Usage & Resolution